DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
Trusted Resources: News & Events
Latest announcements and gatherings
ASH offers early look at updated SCD guidelines: Experts formulated >50 recommendations on sickle cell disease
The American Society of Hematology (ASH) previewed clinical guidelines on sickle cell disease (SCD) here, with the intention of releasing the full set of guidelines in 2019.
The chairs from each of the five SCD guideline panels — sickle cell disease-related transfusion support; sickle cell disease-related cardiopulmonary and kidney disease; sickle cell disease-related cerebrovascular disease; sickle cell disease-related pain; and stem cell transplantation for sickle cell disease — discussed a key recommendation from each of their panels at the ASH annual meeting.
These five SCD panels, which included more than 75 experts across the field, have formulated more than 50 recommendations on SCD. Some draft recommendations veer away from standard practice, or even address issues that haven’t been addressed in previous SCD guidelines.
For example, John F. Tisdale, MD, of the National Heart, Lung, and Blood Institute in Bethesda, Maryland, pointed out that ASH is putting out the first set of guidelines addressing transplantation in SCD, and noted the stem cell transplantation panel’s recommendation of “transplantation at a younger age over transplantation at an older age.”
news & eventsMARAC Advisory Statement: Update About COVID-19 VaccinesSeptember 24, 2021 — News about COVID-...
Community CenterPossible Cure for Sickle Cell Found in ParisHematologists, sickle cell patients, and...
education & researchSickle Cell AnemiaAlthough sickle cell anemia was the firs...
news & eventsMARAC Advisory Statement: Monoclonal Antibodies Against SARS-CoV-2August 26, 2021 – The Sickle Cell Dis...
news & eventsNational Sickle Cell Disease Poll of African Americans Dispels Long-Held ViewsPfizer Inc. (NYSE:PFE), the National New...
news & eventsMARAC Advisory Statement: COVID-19 UpdateAugust 26, 2021 — The Sickle Cell Dise...
Community CenterMalaria-Driven Sickle Cell Trait Selection – Evidence for Modern Day Human Evolution?Sickle cell disease poses a serious heal...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.